Exoskeletons help patients regain mobility

Four years ago, Pablo Albisua Albizu’s life changed forever. Just after heart surgery, this former decorator suffered a stroke that left one side of his body paralysed. Along with undertaking hundreds of rehabilitation sessions, he also volunteered to test a new exoskeleton.

Developed by biomedical engineers, the exoskeleton is made out of aeronautical aluminium. It weighs 12 kilos and it has been designed to assist in the rehabilitation of patients like Pablo, who have suffered strokes.

And it worked, Pablo says.

“Before, when I went shopping in a car, we went around and around to find parking places as close as possible to the shops. And if I was not able to find one, I often just drove back home. I could not find the strength to walk even short distances. Now that has completely changed. I can even go to big shopping malls and I dare to walk around for a long time. That was simply not possible before. I was too tired.”

To read more about the exoskeleton go to: Exoskeletons help patients regain mobility | Euronews

Bio-tech companies and drug-resistant bacteria

There is a feeling amongst small bio-tech companies that their skills are being overlooked in the initiatives being developed to confront the problem of drug-resistant bacteria. An alliance of 37 such companies across Europe have pledged to accelerate progress in dealing with this threat by bringing together expertise in the design and development of new antibiotics, the identification and implementation of preventative strategies against resistance and in the design of improved diagnostic technologies to facilitate more appropriate antibiotic treatment.

The BEAM Alliance says it will remain at the forefront of antibiotic drug, device and diagnostic discovery and development as a combined technical and scientific force across Europe. It also intends to stimulate research and development activities focused on combating antibiotic resistance and to promote new policies and regulation around the use and development of antimicrobial resistance strategies.

For more information, click here on http://beam-alliance.eu